Buprenorphine Implant/Injection (Probuphine, Sublocade)
Customize your policy alerts
Sign up for Arizona Complete Health Policy AZ.CP.PHAR.289 alerts
Get alerted when Policy AZ.CP.PHAR.289 changes without checking for updates manually.
Monitor payer policy activity
Prior authorization and medical-necessity coverage for Probuphine buprenorphine implants and Sublocade buprenorphine injections for Arizona Medicaid members with opioid dependence or opioid use disorder, including initial and continuation criteria, dose limits, documentation requirements, and exclusions.
Probuphine implant criteria were added during the 1Q 2020 annual review.
The concurrent serious mental illness diagnosis requirement for Sublocade was removed.
The requirement that members be older than 18 years for Probuphine and Sublocade was removed.
The policy was clarified to specify that its criteria also apply to Care1st.
The 1Q 2022 annual review reported no significant clinical changes and updated references.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.